A detailed history of Argent Capital Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Argent Capital Management LLC holds 84,735 shares of AMGN stock, worth $29 Million. This represents 0.8% of its overall portfolio holdings.

Number of Shares
84,735
Previous 85,758 1.19%
Holding current value
$29 Million
Previous $24.2 Million 19.64%
% of portfolio
0.8%
Previous 0.67%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 05, 2026

SELL
$290.13 - $341.71 $296,802 - $349,569
-1,023 Reduced 1.19%
84,735 $29 Million
Q3 2025

Oct 14, 2025

SELL
$271.18 - $309.22 $169,216 - $192,953
-624 Reduced 0.72%
85,758 $24.2 Million
Q2 2025

Jul 14, 2025

BUY
$262.28 - $309.85 $656,224 - $775,244
2,502 Added 2.98%
86,382 $24.1 Million
Q1 2025

Jul 14, 2025

BUY
$258.59 - $327.36 $13.6 Million - $17.3 Million
52,707 Added 169.08%
83,880 $26.1 Million
Q4 2024

Jan 14, 2025

SELL
$258.78 - $328.31 $16.1 Million - $20.4 Million
-62,137 Reduced 66.59%
31,173 $8.12 Million
Q3 2024

Oct 22, 2024

BUY
$309.38 - $337.38 $7.44 Million - $8.11 Million
24,051 Added 34.73%
93,310 $30.1 Million
Q2 2024

Jul 24, 2024

SELL
$262.75 - $319.31 $218,870 - $265,985
-833 Reduced 1.19%
69,259 $21.6 Million
Q1 2024

Apr 29, 2024

BUY
$268.87 - $324.56 $18.1 Million - $21.9 Million
67,362 Added 2467.47%
70,092 $19.9 Million
Q2 2021

Aug 10, 2021

SELL
$233.58 - $259.14 $42,044 - $46,645
-180 Reduced 6.19%
2,730 $665,000
Q1 2021

May 12, 2021

SELL
$221.91 - $258.6 $39,943 - $46,548
-180 Reduced 5.83%
2,910 $724,000
Q4 2020

Feb 10, 2021

SELL
$216.38 - $257.67 $37,650 - $44,834
-174 Reduced 5.33%
3,090 $710,000
Q3 2020

Nov 10, 2020

BUY
$234.65 - $260.95 $234 - $260
1 Added 0.03%
3,264 $830,000
Q2 2020

Aug 10, 2020

BUY
$197.81 - $242.74 $395 - $485
2 Added 0.06%
3,263 $770,000
Q1 2020

May 13, 2020

BUY
$182.24 - $241.7 $182 - $241
1 Added 0.03%
3,261 $661,000
Q2 2019

Aug 15, 2019

SELL
$166.7 - $195.41 $161,699 - $189,547
-970 Reduced 22.93%
3,260 $601,000
Q1 2019

May 10, 2019

SELL
$180.87 - $203.88 $76,869 - $86,649
-425 Reduced 9.13%
4,230 $804,000
Q4 2018

Feb 12, 2019

BUY
$178.4 - $208.25 $30,328 - $35,402
170 Added 3.79%
4,655 $906,000
Q3 2018

Nov 13, 2018

BUY
$185.29 - $208.89 $831,025 - $936,871
4,485 New
4,485 $930,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $183B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Argent Capital Management LLC Portfolio

Follow Argent Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Argent Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Argent Capital Management LLC with notifications on news.